Fumagalli E - Search Results

1

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.

Casali PG, Le Cesne A, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom H, Adenis A, Hartmann JT, Duffaud F, Goldstein D, Broto JM, Gronchi A, Dei Tos AP, Marréaud S, van der Graaf WT, Zalcberg JR, Litière S, Blay JY. Casali PG, et al. Among authors: fumagalli e. J Clin Oncol. 2015 Dec 20;33(36):4276-83. doi: 10.1200/JCO.2015.62.4304. Epub 2015 Nov 16. J Clin Oncol. 2015. PMID: 26573069 Clinical Trial.

2

Imatinib mesylate in chordoma.

Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Casali PG, et al. Among authors: fumagalli e. Cancer. 2004 Nov 1;101(9):2086-97. doi: 10.1002/cncr.20618. Cancer. 2004. PMID: 15372471 Free article.

3

Some lessons learned from imatinib mesylate clinical development in gastrointestinal stromal tumors.

Casali PG, Bertulli R, Fumagalli E, Coco P, Grosso F, Stacchiotti S. Casali PG, et al. Among authors: fumagalli e. J Chemother. 2004 Nov;16 Suppl 4:55-8. doi: 10.1179/joc.2004.16.Supplement-1.55. J Chemother. 2004. PMID: 15688611 Review.

4

Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).

Negri T, Bozzi F, Conca E, Brich S, Gronchi A, Bertulli R, Fumagalli E, Pierotti MA, Tamborini E, Pilotti S. Negri T, et al. Among authors: fumagalli e. J Pathol. 2009 Jan;217(1):103-12. doi: 10.1002/path.2450. J Pathol. 2009. PMID: 18973210

5

Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?

Miselli F, Negri T, Gronchi A, Losa M, Conca E, Brich S, Fumagalli E, Fiore M, Casali PG, Pierotti MA, Tamborini E, Pilotti S. Miselli F, et al. Among authors: fumagalli e. Transl Oncol. 2008 Dec;1(4):177-86. doi: 10.1593/tlo.08157. Transl Oncol. 2008. PMID: 19043528 Free PMC article.

6

Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).

Fiore M, Palassini E, Fumagalli E, Pilotti S, Tamborini E, Stacchiotti S, Pennacchioli E, Casali PG, Gronchi A. Fiore M, et al. Among authors: fumagalli e. Eur J Surg Oncol. 2009 Jul;35(7):739-45. doi: 10.1016/j.ejso.2008.11.005. Epub 2008 Dec 24. Eur J Surg Oncol. 2009. PMID: 19110398 Clinical Trial.

7

A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.

Demetri GD, Casali PG, Blay JY, von Mehren M, Morgan JA, Bertulli R, Ray-Coquard I, Cassier P, Davey M, Borghaei H, Pink D, Debiec-Rychter M, Cheung W, Bailey SM, Veronese ML, Reichardt A, Fumagalli E, Reichardt P. Demetri GD, et al. Among authors: fumagalli e. Clin Cancer Res. 2009 Sep 15;15(18):5910-6. doi: 10.1158/1078-0432.CCR-09-0542. Epub 2009 Sep 1. Clin Cancer Res. 2009. PMID: 19723647 Free PMC article. Clinical Trial.

8

Activate and resist: L576P-KIT in GIST.

Conca E, Negri T, Gronchi A, Fumagalli E, Tamborini E, Pavan GM, Fermeglia M, Pierotti MA, Pricl S, Pilotti S. Conca E, et al. Among authors: fumagalli e. Mol Cancer Ther. 2009 Sep;8(9):2491-5. doi: 10.1158/1535-7163.MCT-09-0662. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723893

9

Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study.

Dileo P, Pricl S, Tamborini E, Negri T, Stacchiotti S, Gronchi A, Posocco P, Laurini E, Coco P, Fumagalli E, Casali PG, Pilotti S. Dileo P, et al. Among authors: fumagalli e. Int J Cancer. 2011 Feb 15;128(4):983-90. doi: 10.1002/ijc.25418. Int J Cancer. 2011. PMID: 20473908 Free article.

10

Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.

Da Riva L, Bozzi F, Mondellini P, Miccichè F, Fumagalli E, Vaghi E, Tarantino E, Huber V, Gronchi A, Tamborini E, Pierotti MA, Pilotti S, Bongarzone I. Da Riva L, et al. Among authors: fumagalli e. J Transl Med. 2011 Sep 23;9:158. doi: 10.1186/1479-5876-9-158. J Transl Med. 2011. PMID: 21943129 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page